河北缩小脊柱骨和骨盆、半腿骨模型上饶中医舌诊图像分析系统（便携式）,北京泪道冲洗操作训练模型,拉萨宫腔镜模拟训练器,陕西口腔缝合练习模型,葫芦岛头颈部中层解剖模型,枣庄儿童腹腔穿刺培训模型,广东女性盆部横断断层解剖模型

COLORADO SPRINGS, Colo. — More than 150 students at Colorado College are being quarantined for the next two weeks after one tested positive for the COVID-19 over the weekend.“At first I was like, shocked, but after a little while it sunk in like, 'Wow, that’s 14 days in one room,'” said Colorado College freshman Andrew Kaelin.Kaelin and Oliver Kendall only met Saturday. On Sunday, these roommates found out they will be spending nearly every minute of the next two weeks with each other. Students are allowed to only leave the room for laundry, bathroom and water. Food for the day is delivered to the room.“It’s a good way to get to know someone,” Kendall said.Before moving in, all students were required to take a COVID-19 test and were asked to isolate in their dorm rooms until the results came back.Brian Young, with Colorado College, said the student who tested positive went into the hallway of the dorm rather than staying in the room.“Immediately, as we isolated, the individual did our contact trace, realized, unfortunately, (that they) didn’t follow the guidelines we were after,” Young said.Neither Young or the El Paso County Health Department could say exactly how many came in contact with the student. Whatever the number was, it was enough to lock down Loomis Hall and the 155 first-year students living there.“All of our students are doing fine. No one is symptomatic,” Young told KMGH.Young said anyone showing even one symptom will be tested immediately. Colorado College is also providing students the ability to speak to a mental health expert as needed. Young says students will be allowed to get some fresh air with supervision.This story was originally published by Gary Brode at KMGH. 1723

Coca-Cola last month teased the possibility it could get into the cannabis business. But the beverage maker now says it's not interested in pot.CEO James Quincey said the company "doesn't have any plans at this stage" to enter the CBD market, during an earnings conference call with analysts Tuesday.CBD is a non-psychoactive component of marijuana.Quincey's comments came in response to a question from Cowen & Co. analyst Vivien Azer, who asked about rumors that Coca-Cola (KO) was looking at the CBD category.Coke said in September that it was "closely watching" the growth of CBD as a possible ingredient for so-called wellness beverages. At the same time rumors swirled that Coke was considering an investment in Canadian cannabis company Aurora (ACB).It looks like Coke decided to pass.Shares of Aurora, which just began trading on the New York Stock Exchange last week, rallied nonetheless on Tuesday. So did shares of fellow Canadian pot stocks Cronos (CRON), Aphira (APHQF) and Canopy Growth (CGC).Even though Coke shot down chatter of an imminent deal with Aurora or other cannabis companies, there is still growing interest in CBD from larger global consumer companies ever since recreational marijuana became legal in Canada earlier this month.Coke's archrival Pepsi (PEP) hasn't completely ruled out a move into cannabis. Chief Financial Officer Hugh Johnston told analysts during its earnings call earlier this month that "it's fair to say we look at everything" in response to a question about cannabis.But Johnston added that investing in CBD, especially in the United States, would be a "considerable challenge" as long as marijuana remains illegal on a federal level. It's legal in nine states and D.C.That murky legal status hasn't kept the beer and spirits makers at bay.Corona owner Constellation Brands (STZ) has a more than billion stake in Canopy Growth.The Canadian subsidiary of Molson Coors (TAP) has a joint venture with The Hydropothecary Corporation to produce cannabis-infused drinks for the Canadian market.Tobacco giant Altria (MO), the owner of Marlboro, may be mulling a stake in Aphria, which is also set to debut on the NYSE later this week. UK alcoholic beverage giant Diageo (DEO) also could be interested in cannabis.And although Budweiser maker Anheuser-Busch InBev (BUD) has so far not shown a willingness to get into the cannabis business, Adolphus A. Busch V, great-great-grandson of Anheuser-Busch's founder, recently launched a cannabis brand. 2529

Co-founders of Tinder and eight other former and current executives of the popular dating app are suing the service's current owners, alleging that they manipulated the valuation of the company to deny them of billions of dollars they were owed.The suit, filed Tuesday in state court in New York, seeks at least billion in damages from Match Group and its parent company, IAC/InterActiveCorp. The plaintiffs are represented by Orin Snyder of Gibson Dunn, who has represented some of the biggest companies in tech, including Facebook, Apple and Uber.The dispute centers on an analysis of Tinder done in 2017 by Wall Street banks to set a value for stock options received by Sean Rad, a Tinder co-founder, and other early employees. It also includes an allegation of sexual harassment against Tinder's former CEO, Greg Blatt.CNN has reached out to IAC, Blatt and IAC for comment multiple times, and has yet to hear back. We will update this story when or if we get one. 978

Corporate America is coming to Wall Street's rescue.The Dow soared?548 points, or 2.2%, on Tuesday as investors cheered fat profits from major companies and relative calm in the bond market. The huge rally, the Dow's best day since March, helped the index recover a chunk of last week's hefty losses.Tech stocks, the biggest losers during the market turmoil, raced back to life. The Nasdaq spiked nearly 3%, while the S&P 500 advanced 2.2%.Investors piled back into tech darlings. Amazon, Facebook and Netflix closed sharply higher."It's a bounce back after an overdone situation last week," said David Joy, chief market strategist at Ameriprise Financial.Market sentiment was lifted by earnings beats from Goldman Sachs, Morgan Stanley and Johnson & Johnson. Adobe and UnitedHealth added to the good news by offering upbeat guidance for 2019.Taken together, the corporate report cards underscore the ability of businesses to cash in on the strong US economy. And the results should ease fears about the US-China trade war."We're focusing back on fundamentals," said Dan Suzuki, portfolio strategist at Richard Bernstein Advisors. Suzuki called Tuesday's rally a "reflexive rebound."Last week, the Dow, S&P 500 and Nasdaq all suffered their worst week since March. At one point, the Dow plummeted more than 1,000 points in just two trading days.Despite Tuesday's advance, all three major indexes remain firmly in the red for the month.One major source of investor nervousness has improved: bond yields. A sudden spike in 10-year Treasury rates above 3.25% spooked markets. The rapid climb in rates was driven by the strong economy, the surging federal deficit?and concerns about a more aggressive Federal Reserve.Investors feared higher borrowing costs that could slow growth and sudden competition for the stock market from boring bonds.But Treasury rates, which move in the opposite direction of prices, eased late last week as investors poured cash into the safety of government bonds. Rates have stabilized at around 3.15%, relieving stock market bulls."That has reassured people that this is not the start of something much worse that could really sidetrack the market," said Bruce McCain, chief investment strategist at Key Private Bank. 2288

CVS and Walgreens are gearing up to give coronavirus vaccines - in long-term care facilities, not retail stores - once the FDA approves one for emergency use.According to CNN, CVS would administer the shots by mid-December, and Walgreens plans to start distributing within days of receiving them.In October, the U.S. Department of Health and Human Services (HHS) announced agreements with both companies to give vaccinations to long-term care facility residents nationwide with no out-of-pocket costs.According to the HHS, both companies will schedule and coordinate on-site clinic date(s) directly with each facility.The HHS said that residents and staff would likely need three total visits over two months to be given both vaccine doses."CVS Health has been on the frontlines of the fight against COVID-19, working across the health care spectrum in all the communities we serve, and that will continue to be the case when we have a vaccine to dispense," said Troy Brennan, Chief Medical Officer, CVS Health in a press release.On Tuesday, the CDC's Advisory Committee for Immunization Practices is having an emergency meeting, which will take place from 2-5 p.m. ET, to vote on who they recommend should be the first in the U.S. to get vaccinated once one is authorized. 1281